You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Deferasirox

Showing 76 - 100 of 114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thalassemia, Iron Overload, Hemochromatosis Trial run by the NIDDK (Nifedipine, Phlebotomy, Urinalysis)

Completed
  • Thalassemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Transfusional Iron Overload Trial in Greece, Italy, United States (ICL670)

Completed
  • Transfusional Iron Overload
  • Oakland, California
  • +17 more
Feb 21, 2017

Children Aged 2 to <6 Years With Transfusional Iron Overload

Completed
  • Anemia
  • Deferasirox
  • Mobile, Alabama
  • +22 more
Dec 26, 2015

Renal Function Among Thalassemia Patients Treated byOral

Completed
  • Thalassemia
  • Iron Overload
  • Deferasirox
  • Afula, Israel
    Ha'Emek Medical Center
Aug 30, 2015

Systemic Inflammatory Process, Anemia Trial (iron sucrose, Deferasirox, endotoxin)

Completed
  • Systemic Inflammatory Process
  • Anemia
  • iron sucrose
  • +3 more
  • (no location specified)
Nov 16, 2015

Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With

Unknown status
  • Aplastic Anemia
  • +2 more
    • (no location specified)
    Jul 13, 2016

    Transfusional Iron Overload Trial in Italy (Deferasirox)

    Completed
    • Transfusional Iron Overload
    • Deferasirox
    • Cagliari, Italy
    • +3 more
    Mar 18, 2015

    High-Tc Susceptometer to Monitor Transfusional Iron Overload

    Completed
    • Transfusional Iron Overload
    • +4 more
    • Hepatic biomagnetic susceptibility measurement
    • New York, New York
      Columbia University Medical Center
    Sep 20, 2016

    Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)

    Completed
    • Atrial Fibrillation
    • São Paulo, Brazil
      Hospital São Paulo/Hospital Universitário da UNIFESP (University
    Nov 21, 2016

    Transfusional Iron Overload, Transfusional Hemosiderosis Trial in Worldwide (Core Study: Deferasirox, Core Study: Deferoxamine,

    Completed
    Has Results
    • Transfusional Iron Overload
    • Transfusional Hemosiderosis
    • Core Study: Deferasirox
    • +5 more
    • Toronto, Ontario, Canada
    • +20 more
    Aug 13, 2014

    Beta-thalassemia Major Trial (DFX(Deferasirox), DFP(Deferiprone))

    Completed
    • Beta-thalassemia Major
    • (no location specified)
    Jul 22, 2014

    Hereditary Anemias Trial in Vancouver (Fibroscan)

    Unknown status
    • Hereditary Anemias
    • Fibroscan
    • Vancouver, British Columbia, Canada
      St. Paul's Hospital
    Jan 13, 2016

    Porphyria Cutanea Tarda Trial in Dallas (Deferasirox)

    Completed
    Has Results
    • Porphyria Cutanea Tarda
    • Deferasirox
    • Dallas, Texas
      UT Southwestern Medical Center at Dallas - Dermatology Clinical
    Jan 9, 2014

    Myelodysplastic Syndrome Trial in Holon (Exjade)

    Completed
    • Myelodysplastic Syndrome
    • Holon, Israel
      Wolfsom Medical Center
    Jun 13, 2014

    Pharmacogenetic Study in Patients Received Iron Chelating Agent

    Completed
    • Hemosiderosis
      • Seoul, Chongno-gu, Korea, Republic of
        Seoul National University Hospital
      Jul 11, 2014

      Adult and Pediatric Transfusion-dependent Patients Treated With

      Completed
      • Iron Overload
        • (no location specified)
        Jun 6, 2013

        Non-transfusion Dependent Thalassemia Trial in Worldwide (deferasirox, )

        Completed
        Has Results
        • Non-transfusion Dependent Thalassemia
        • deferasirox
        • placebo
        • Oakland, California
        • +20 more
        May 20, 2013

        Non-alcoholic Steatohepatitis, Increased Iron Storage / Disturbed Distribution Trial in Germany (Exjade)

        Completed
        • Non-alcoholic Steatohepatitis
        • Increased Iron Storage / Disturbed Distribution
        • Balingen/Hechingen, Germany
        • +8 more
        Jul 19, 2012

        Active Drug Surveillance Program of Ferriprox Use

        Completed
        • Transfusional Iron Overload
          • Nicosia, Cyprus
          • +13 more
          Apr 19, 2013

          Iron Overload Trial in Spain (deferasirox)

          Completed
          • Iron Overload
          • deferasirox
          • Andalucia, Spain
          • +8 more
          Apr 27, 2012

          Beta-thalassemia Major, Sickle Cell Disease, Iron Hemosiderosis Trial in Cairo (DFP (ferriprox) and deferasirox (ICL 670), DFP,

          Unknown status
          • Beta-thalassemia Major
          • +2 more
          • DFP (ferriprox) and deferasirox (ICL 670)
          • DFP, DFO
          • Cairo, Egypt
            Pediatric Hematology clinic, Ain Shams University
          Feb 3, 2012

          Beta-Thalassemia Trial in United States (ICL670, deferoxamine)

          Completed
          • Beta-Thalassemia
          • Los Angeles, California
          • +6 more
          Apr 18, 2012

          Sickle Cell Disease: A Retrospective Chart Review

          Completed
          • Sickle Cell Anemia
            • New Orleans, Louisiana
            • +1 more
            Oct 17, 2012

            Mucormycosis Trial in United States (deferasirox, Placebo, Liposomal amphotericin B)

            Completed
            Has Results
            • Mucormycosis
            • deferasirox
            • +2 more
            • Duarte, California
            • +6 more
            Sep 2, 2011

            Collaborative Seamless Care in Oncology : Measure and Reinforce

            Unknown status
            • Cancer
              • Lausanne, Vaud, Switzerland
                Policlinique Médicale Universitaire and Centre pluridisciplinair
              Jul 16, 2012